On the bourses around 10:15 AM, Petronet LNG shares were struggling as the scrip was trading 1.31% lower at ₹273.95. In comparison, BSE Sensex was trading 0.29% lower at 83,289.99 levels.
Led by the India business and rest-of-the-world markets, the company reported a robust 14.3 per cent year-on-year (Y-o-Y) growth in revenues
Brokerages bullish on stock amid easing leverage situation
Zydus Life Q2 results review: Foreign brokerage Nomura said Zydus Life delivered results above estimates, led by a stronger-than-expected performance in India.
Specialty portfolio powers Q2; Ilumya, Leqselvi, Unloxcyt to anchor next phase
According to analysts, Paytm is focussing in propelling its profitability flywheel by adopting a structural cost discipline, and adopting a margin-accretive mix. Read Paytm stock analysis
With operational cell/module capacity of 5.4 GW/16.1 GW in India, WEL, analysts believe, towers domestic competitors and enjoys a formidable India capacity market share of 21.6 per cent/13.3 per cent
On track for continued outperformance in FY26 with strategic launches, premiumisation
Tata Consumer Products reported strong revenue growth led by its India business. Analysts expect margins to improve in H2FY26 as tea prices moderate and premium segments expand.
Tata Consumer Outook: Analysts believe the consumer goods major is reclaiming its high-growth momentum under CEO Sunil D'Souza, backed by strong execution, premiumisation, and sustained innovation.
For Q2, the company recorded sales of ₹4,330 crore, which was six times higher than the year-ago period
Maruti Suzuki Q2 results: Motilal Oswal said Maruti Suzuki's Q2FY26 PAT was in line, while margins beat estimates due to an improved mix.
Vedanta's consolidated revenue for Q2FY26 rose 6 per cent Y-o-Y to ₹39,218 crore, while Ebitda jumped 12 per cent Y-o-Y to ₹11,612 crore, with margins expanding 69 bps to 34 per cent.
Exports, lean costs, and tax cuts keep growth engines humming, but next bend will call for sharper steering
Dabur Q2 results: Dabur reported a 5.4 per cent year-on-year (Y-o-Y) rise in consolidated sales, led by 4.3 per cent growth in the domestic business, while India volume growth stood at 2 per cent.
Motilal Oswal has initiated coverage on Rubicon Research, a pharmaceutical manufacturing company, with a 'Buy' rating
Brokerages were unanimous that the non-cigarette FMCG business remains a bright spot in ITC's portfolio.
Nuvama has reiterated its 'Buy' rating, raising the sum-of-the-parts (SOTP)-based target price to ₹413 (from ₹401 earlier).
Varun Beverages share price fell 2% after Q3CY25 results despite 19% profit growth. Analysts stay positive, citing Africa expansion, Carlsberg tie-up, and steady demand outlook.
Motilal Oswal, however, remained upbeat on Coal India, calling the earnings a 'big miss due to high costs' but maintaining its 'Buy' rating with a target price of ₹440.